It was also noteworthy that a recent preclinical study demonstrated that EEF1A2 knockdown suppresses lung cancer brain metastasis by inhibiting the BCL10/NFκB pathway and reversing EMT [89], further validating the therapeutic potential of targeting eEF1A isoforms in advanced cancers. The gene discussed is NFKB1; the disease is cancer.